The receptor binding properties of H5Ny influenza A viruses have evolved to bind to avian-type mucin-like O-glycans.
Saved in:
| Title: | The receptor binding properties of H5Ny influenza A viruses have evolved to bind to avian-type mucin-like O-glycans. |
|---|---|
| Authors: | Weber J; Department of Chemical Biology & Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg Utrecht, Utrecht, The Netherlands.; Institute of Applied Synthetic Chemistry, Vienna University of Technology, Vienna, Austria., Ponse NLD; Department of Chemical Biology & Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg Utrecht, Utrecht, The Netherlands., Zhu X; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America., Ríos Carrasco M; Department of Chemical Biology & Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg Utrecht, Utrecht, The Netherlands., Han AX; Department of Medical Microbiology & Infection Prevention, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands., Funk M; Department of Viroscience, Erasmus University Medical Center, Rotterdam, The Netherlands., Lin TH; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America., Gabarroca García A; Department of Chemical Biology & Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg Utrecht, Utrecht, The Netherlands., Spruit CM; Department of Chemical Biology & Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg Utrecht, Utrecht, The Netherlands., Zhang D; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America., Yu W; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America., Wilson IA; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.; Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, California, United States of America., Richard M; Department of Viroscience, Erasmus University Medical Center, Rotterdam, The Netherlands., Boons GJ; Department of Chemical Biology & Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg Utrecht, Utrecht, The Netherlands.; Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia, United States of America., de Vries RP; Department of Chemical Biology & Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg Utrecht, Utrecht, The Netherlands. |
| Source: | PLoS pathogens [PLoS Pathog] 2026 Jan 20; Vol. 22 (1), pp. e1013812. Date of Electronic Publication: 2026 Jan 20 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1553-7374 |
|---|---|
| DOI: | 10.1371/journal.ppat.1013812 |
